Paper Details

  1. Home
  2. Paper Details

Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.

Author: BoehmAndreas, CentofantiMarco, GoldblumDavid, KarabatsasCostas H, RossettiLuca, TopouzisFotis, VetrugnoMichele, ViswanathanAnanth, VorwerkChristian

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Bimatoprost and a fixed combination of latanoprost and timolol were found to be equally effective in maintaining intraocular pressure at controlled levels over a 24-hour period. This randomized, double-masked, multicenter clinical trial involved 200 patients with glaucoma or ocular hypertension who were switched from a nonfixed combination of latanoprost and timolol.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To compare the effect of bimatoprost and the fixed combination of latanoprost and timolol (LTFC) on 24-hour mean intraocular pressure (IOP) after patients are switched from a nonfixed combination of latanoprost and timolol. DESIGN: Randomized, double-masked, multicenter clinical trial. ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ophtha.2007.01.025

データ提供：米国国立医学図書館（NLM）

Bimatoprost vs. Latanoprost/Timolol: A Comparative Study

The

ocular system

is like a camel's eyes – vital for navigating its surroundings.

Glaucoma

, a condition that affects eye pressure, can impair vision. This study compares the effectiveness of

bimatoprost

and a fixed combination of

latanoprost

and

timolol

(LTFC) in managing intraocular pressure (IOP).

Maintaining Eye Pressure: A Balancing Act

The study found that bimatoprost is not inferior to LTFC in maintaining IOP at a controlled level over a 24-hour period. The researchers also observed differences in IOP fluctuations between the two treatments. This information can help doctors choose the best medication for individual patients based on their specific needs and preferences.

Protecting Your Vision

If you're diagnosed with glaucoma, it's essential to work closely with your ophthalmologist to manage your eye pressure. They can guide you through different treatment options and help you make informed decisions about your care. Remember, just as a camel uses its keen eyesight to navigate the desert, we rely on our vision to experience the world around us.

Dr.Camel's Conclusion

This research provides valuable insights into the treatment of glaucoma, emphasizing the need for a personalized approach that considers individual patient needs. By understanding the unique characteristics of different medications, ophthalmologists can make more informed decisions about treatment, ensuring that patients maintain optimal eye health and vision.

Date :
  1. Date Completed 2007-12-18
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17459480

DOI: Digital Object Identifier

10.1016/j.ophtha.2007.01.025

Related Literature

Article Analysis
・Effects of timolol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.